Form 4 for STLN Starling Oncology, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001628280-23-041777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-18 | 2023-12-14 | STLN | Shah Mihir | CFO | P - Purchase | $1.27 | +100.0K | 327.6K | +44% | +$127.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-12-14 | P | A | 565 | $1.25 | 328,122 | D | — | — | |
| 2 | Common | Common stock | 2023-12-14 | P | A | 99,435 | $1.27 | 327,557 | D | — | — |